WebApr 10, 2024 · Eris Lifesciences Limited manufactures, markets, and distributes pharmaceutical products in India. About the company Rewards Price-To-Earnings ratio (20.2x) is below the Indian market (21.4x) Earnings are forecast to grow 11.48% per year Earnings grew by 0.8% over the past year Risk Analysis Dividend of 1.24% is not well … WebDec 28, 2024 · Motilal Oswal bullish on Eris Lifesciences; initiates coverage with buy By Ekta Batra Dec 29, 2024 8:44 AM IST (Updated) Mini Motilal Oswal Financial …

Eris Lifesciences Key Financial Ratios, Eris Lifesciences Financial ...

WebINITIATING COVERAGE BOB Capital Markets Ltd is a wholly owned subsidiary of Bank of Baroda Important disclosures, including any required research certifications, are provided at the end of this report. ... Eris Lifesciences’ (ERIS) earnings are at inflection point and we expect a 16% EBITDA CAGR over FY21-FY24 (vs. 8%, FY18-FY21). Presence in ... WebDec 28, 2024 · In just 14 years Eris Lifesciences Ltd. has built a pure-play branded formulation business, with a revenue of Rs 13 billion. Notably, its profit after tax has … grass fed whey protein over rated

Eris Lifesciences Ltd. Brokerage/Research Reports, analyst …

Web• Initiate coverage on Eris Lifesciences (ERIS) with a BUY rating and a target price of INR870. • ERIS has presence across the value chain in developing, manufacturing, and marketing of branded pharma products in select Chronic therapies (the fastest growing company in Chronic category), such as Anti-Diabetes (AD; 37% of sales), WebEris Lifesciences Initiating Coverage) The Pharma Brand Master Ashoka Buildcon Divestment of BOT toll assets removes a big overhang PAT to exhibit 17% growth over … WebERIS LIFESCIENCES LIMITED Our Company was incorporated as “Eris Lifescience Private Limited” on January 25, 2007, as a private limited company under the Companies … grass fed whole milk kefir